<< First study to mathematically quantify the emotional impact of music | Scottish hospitalisation for angina and chest pain has risen dramatically in the last decade >>
Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Ελληνικά | עִבְרִית | Bahasa | Русский | Svenska | Polski

Helminthic therapy, using worm eggs to treat patients with inflammatory bowel disorders

Published on May 21, 2004 at 7:45 PM · No Comments
University of Iowa Health Care researchers reported important findings recently at a conference of specialists in New Orleans, La. The findings are from their study of helminthic therapy - using specially prepared worm eggs - to treat patients diagnosed with inflammatory bowel disorders that don't respond to standard treatments.

The UI researchers' work showed that helminthic therapy is promising in the treatment of patients diagnosed with inflammatory bowel disease whose symptoms did not respond to current therapies.

"We were able to show that treating these patients with helminths appears to relieve symptoms and help control the disease. Also, they tolerate the treatments without experiencing side effects or complications," said Joel Weinstock, M.D. (left), UI professor of internal medicine and director of the Digestive Diseases Center at UI Hospitals and Clinics.

UI Health Care researchers reported this week on the outcome of a placebo-controlled, double blind study of 54 patients diagnosed with ulcerative colitis. The UI team also collaborated with other researchers in Europe and Canada.

David Elliott, M.D. (right), UI associate professor of internal medicine, conducted animal studies that played a key role in developing the therapy. He showed that exposure of mice to helminthic worms protected them from development of experimental inflammatory bowel disease.

Robert Summers, M.D. (left), UI professor of internal medicine, organized a clinical study to determine if a helminthic parasite could be given safely to patients with inflammatory bowel disease and help control the disease.

The UI researchers say more studies are needed before helminthic therapy can be provided on a widespread basis.

"We have more work to complete before this approach can be routinely used, but we are very encouraged by our results thus far," Weinstock said. "We may be on the verge of a new era in the treatment of these very serious disorders."

These studies were supported by the Crohn's and Colitis Foundation of America, the Broad Foundation and the National Institutes of Health.

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading